TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Actelion Pharmaceuticals Sverige AB
Closing information (x1000 SEK)
Closing information | 2018/12 | 2017/12 | 2016/12 |
Turnover | 258,993 | 249,820 | 223,999 |
Financial expenses | 2,102 | 3,120 | 39 |
Earnings before taxes | 10,572 | 16,583 | 10,113 |
EBITDA | 10,515 | 18,692 | 6,044 |
Total assets | 184,381 | 161,329 | 137,105 |
Current assets | 184,128 | 160,658 | 136,202 |
Current liabilities | 130,965 | 112,287 | 99,246 |
Equity capital | 53,416 | 49,042 | 34,946 |
- share capital | 1,000 | 1,000 | 1,000 |
Employees (average) | 29 | 28 | 29 |
Financial ratios
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Solvency | 29.0% | 30.4% | 25.5% |
Turnover per employee | 8,931 | 8,922 | 7,724 |
Profit as a percentage of turnover | 4.1% | 6.6% | 4.5% |
Return on assets (ROA) | 6.9% | 12.2% | 7.4% |
Current ratio | 140.6% | 143.1% | 137.2% |
Return on equity (ROE) | 19.8% | 33.8% | 28.9% |
Change turnover | 9,173 | 25,821 | 7,917 |
Change turnover % | 4% | 12% | 4% |
Chg. No. of employees | 1 | -1 | 1 |
Chg. No. of employees % | 4% | -3% | 4% |
Total value of public sale
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.